Education
About Us
Working with TipRanks
Follow Us
Top UK Pharma & Biotech Shares
Comparison Results
Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 13716.00p | 126.25K | xxxxxxxxxxxxx | 12 Buy 2 Hold 1 Sell Moderate Buy | £211.95B | 29.44 | 1.53% | Healthcare | |||
 | 1812.25p | 1.00M | xxxxxxxxxxxxx | 3 Buy 8 Hold 3 Sell Hold | £73.51B | 13.47 | 3.30% | Healthcare | |||
 | 1529.47p | 44.21K | xxxxxxxxxxxxx | 4 Buy 1 Hold 0 Sell Strong Buy | £3.33B | 11.67 | 4.17% | Healthcare | |||
 | 198.00p | 13.83K | xxxxxxxxxxxxx | 4 Buy 0 Hold 0 Sell Strong Buy | £1.73B | 4.80 | ― | Healthcare | |||
 | ― | ― | xxxxxxxxxxxxx | ― | ― | ― | ― | ― |
Performance Comparison
GB:AZN
AstraZeneca
13,632.00
3,430.87
33.63%
GB:GSK
GlaxoSmithKline
1,810.00
532.21
41.65%
GB:HIK
Hikma Pharmaceuticals
1,523.00
-401.00
-20.84%
GB:HCM
HUTCHMED (China)
198.00
-31.00
-13.54%
GB:DPH
Dechra Pharmaceuticals
―
―
―
Pharma & Biotech Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Nov 06, 2025
Dec 01, 2025
155.022
GlaxoSmithKline
Oct 29, 2025
Dec 01, 2025
23.2
Hikma Pharmaceuticals
Aug 07, 2025
Dec 01, 2025
34.639
HUTCHMED (China)
Aug 07, 2025
Dec 01, 2025
1.038
Dechra Pharmaceuticals
―
―
―
―
Pharma & Biotech - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
Hikma Pharmaceuticals - Strong Buy, based on 5 analyst ratings, 4 Buy, 1 Hold, and 0 Sell.
HUTCHMED (China) - Strong Buy, based on 4 analyst ratings, 4 Buy, 0 Hold, and 0 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 13,716.00p, and its average 12-month price target is 14,551.32p.
GlaxoSmithKline's stock price is currently 1,812.25p, and its average 12-month price target is 1,771.67p.
Hikma Pharmaceuticals's stock price is currently 1,529.47p, and its average 12-month price target is 2,266.00p.
HUTCHMED (China) 's stock price is currently 198.00p, and its average 12-month price target is 312.16p.
Dechra Pharmaceuticals's stock price is currently N/A, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline does not currently pay dividends.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) does not currently pay dividends.
Dechra Pharmaceuticals does not currently pay dividends.
Popular Stocks Comparisons
Latest News
Pharma & Biotech Stock Events
Stock | Type | Date |
|---|---|---|
GlaxoSmithKline | Earnings Release | Feb 04, 2026 |
AstraZeneca | Earnings Release | Feb 10, 2026 |
Hikma Pharmaceuticals | Earnings Release | Feb 26, 2026 |
HUTCHMED (China) | Earnings Release | Feb 26, 2026 |
AstraZeneca | Earnings Release | Apr 29, 2026 |